Skip to main content
logo
Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
40.47
+0.32 (0.80%)
At close: Nov 18, 2025, 4:00 PM EST
40.70
+0.23 (0.57%)
After-hours: Nov 18, 2025, 7:54 PM EST

Arrowhead Pharmaceuticals Revenue

Arrowhead Pharmaceuticals had revenue of $27.77M in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $572.98M, up 2,816.21% year-over-year. In the fiscal year ending September 30, 2024, Arrowhead Pharmaceuticals had annual revenue of $3.55M, down -98.52%.

Revenue (ttm)
$572.98M
Revenue Growth
+2,816.21%
P/S Ratio
9.21
Revenue / Employee
$940,847
Employees
609
Market Cap
5.60B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 20243.55M-237.18M-98.52%
Sep 30, 2023240.74M-2.50M-1.03%
Sep 30, 2022243.23M104.94M75.89%
Sep 30, 2021138.29M50.30M57.16%
Sep 30, 202087.99M-80.80M-47.87%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

ARWR News

More News